| First Author | Barazzone Argiroffo C | Year | 2002 |
| Journal | Am J Pathol | Volume | 160 |
| Issue | 1 | Pages | 67-71 |
| PubMed ID | 11786400 | Mgi Jnum | J:108197 |
| Mgi Id | MGI:3623198 | Doi | 10.1016/S0002-9440(10)64350-7 |
| Citation | Barazzone Argiroffo C, et al. (2002) CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury. Am J Pathol 160(1):67-71 |
| abstractText | Recent studies suggest that apoptosis plays a role in oxygen-induced injury, although the activation pathways and the executioner proteases that lead to cleavage of lung cell proteins and DNA, are not yet identified. We explored previously the tumor necrosis factor/tumor necrosis factor receptor and the Fas/FasL, belonging to the intrinsic pathway, and could not demonstrate any protective effect by interfering with these cell receptors. Lately, it has been shown that interacting with the CD40 system, also known to promote cell death, by administering anti-CD40 ligand (L) antibody was beneficial in several diseases and, in particular, in hyperoxia-induced injury. Using CD40- and CD40L-deficient mice (-/-) as well as administering anti-CD40L antibody, we examined the extent of lung injury in oxygen-breathing mice by several ways (lung weight, histology, inflammatory mediators, and DNA ladder) as well as the mortality. The development of lung injury was similar in wild-type, CD40-/-, CD40L-/-, or in wild-type mice treated with anti-CD40L antibody. Apoptosis was present in all conditions at 72 hours of oxygen exposure. These results show that oxygen-induced injury does not require CD40-CD40L interaction and that apoptosis of lung cells does not involve this pathway. |
